APM
Avidity Partners Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.6M | Sell |
154,000
-168,100
| -52% | -$6.11M | 1.12% | 33 |
|
|
2025
Q1 | $11.7M | Sell |
322,100
-29,900
| -8% | -$1.08M | 2.22% | 12 |
|
|
2024
Q4 | $14.8M | Sell |
352,000
-400,000
| -53% | -$16.8M | 1.45% | 30 |
|
|
2024
Q3 | $41.8M | Sell |
752,000
-208,000
| -22% | -$11.6M | 2.13% | 17 |
|
|
2024
Q2 | $39.5M | Buy |
960,000
+26,500
| +3% | +$1.09M | 1.68% | 22 |
|
|
2024
Q1 | $43.6M | Buy |
933,500
+89,000
| +11% | +$4.16M | 1.41% | 22 |
|
|
2023
Q4 | $40.4M | Buy |
844,500
+300,500
| +55% | +$14.4M | 1.47% | 31 |
|
|
2023
Q3 | $19.4M | Sell |
544,000
-356,700
| -40% | -$12.7M | 0.78% | 48 |
|
|
2023
Q2 | $41.5M | Sell |
900,700
-1,226,200
| -58% | -$56.6M | 1.45% | 28 |
|
|
2023
Q1 | $85.3M | Sell |
2,126,900
-863,100
| -29% | -$34.6M | 2.83% | 9 |
|
|
2022
Q4 | $139M | Buy |
2,990,000
+938,400
| +46% | +$43.5M | 3% | 9 |
|
|
2022
Q3 | $85M | Buy |
2,051,600
+572,100
| +39% | +$23.7M | 1.73% | 22 |
|
|
2022
Q2 | $88.3M | Buy |
1,479,500
+610,500
| +70% | +$36.4M | 2.03% | 23 |
|
|
2022
Q1 | $63.1M | Buy |
869,000
+169,000
| +24% | +$12.3M | 1.31% | 23 |
|
|
2021
Q4 | $58.9M | Buy |
700,000
+245,000
| +54% | +$20.6M | 1.25% | 30 |
|
|
2021
Q3 | $41M | Buy |
+455,000
| New | +$41M | 0.91% | 35 |
|